Larimar Therapeutics (LRMR) Share-based Compensation Growth (1y) (2014 - 2025)
Larimar Therapeutics (LRMR) Share-based Compensation Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | -81.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -81.31% |
| Sep 30, 2025 | 27.75% |
| Jun 30, 2025 | -20.56% |
| Mar 31, 2025 | 50.38% |
| Dec 31, 2024 | 334.36% |
| Sep 30, 2024 | 7.47% |
| Jun 30, 2024 | 12.68% |
| Mar 31, 2024 | 16.09% |
| Dec 31, 2023 | 16.74% |
| Sep 30, 2023 | 9.24% |
| Jun 30, 2023 | 21.91% |
| Mar 31, 2023 | 12.11% |
| Dec 31, 2022 | 11.01% |
| Sep 30, 2022 | 13.94% |
| Jun 30, 2022 | 24.07% |
| Mar 31, 2022 | 38.56% |
| Dec 31, 2021 | 46.53% |
| Sep 30, 2021 | 295.41% |
| Jun 30, 2021 | 79.52% |
| Mar 31, 2021 | 3,968.97% |